These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11190124)

  • 1. Research infrastructure and IRB/FDA requirements.
    Cohen J
    Med Health R I; 2000 Dec; 83(12):382-5. PubMed ID: 11190124
    [No Abstract]   [Full Text] [Related]  

  • 2. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
    Cohen J;
    AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IRB as deputy sheriff: proposed FDA regulation of the institutional review board.
    Huff TA
    Clin Res; 1979 Apr; 27(2):103-8. PubMed ID: 10241072
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical research. Shutdown at Hopkins sparks a debate.
    Marshall E
    Science; 2001 Jul; 293(5530):587-9. PubMed ID: 11474076
    [No Abstract]   [Full Text] [Related]  

  • 5. A legal framework for clinical trials in correctional settings.
    Lazzarini Z
    Med Health R I; 2000 Dec; 83(12):386-9. PubMed ID: 11190125
    [No Abstract]   [Full Text] [Related]  

  • 6. A lesson from Melos.
    Owen JA
    Hosp Formul; 1979 Feb; 14(2):127. PubMed ID: 10240142
    [No Abstract]   [Full Text] [Related]  

  • 7. Recruiting human subjects without IRB review/approval.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA scrutiny and pediatric clinical investigations.
    Kadzielski MA; Gordon JH
    Cost Qual; 2001 Jun; ():33-6. PubMed ID: 11482257
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
    Nightingale SL
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials within the Florida Department of Corrections.
    Fischl M
    Med Health R I; 2000 Dec; 83(12):393. PubMed ID: 11190127
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60353-6. PubMed ID: 10187395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials.
    Hoffman S
    Indiana Law Rev; 2000; 33(2):475-515. PubMed ID: 16189915
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 16. US ponders unlocking the gates to prisoner research.
    Waltz E
    Nat Med; 2006 Jan; 12(1):3. PubMed ID: 16397531
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of human research subjects: proposed rule.
    Fed Regist; 1979 Aug; 44(158):47687-729. PubMed ID: 10242808
    [No Abstract]   [Full Text] [Related]  

  • 18. To IRB or not to IRB? That is no longer the question.
    Lehman CM; Rodgers GM
    Am J Clin Pathol; 2001 Feb; 115(2):187-91. PubMed ID: 11211606
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. University failed to have adequate IRB policies and procedures in place.
    Maloney DM
    Hum Res Rep; 2002 Mar; 17(3):6-7. PubMed ID: 12408153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.